The treatment of EF ethanol extract in benign prostatic hyperplasia-1 cells inhibits cell viability through caspase-8 and cystatin-3-dependent apoptosis and effectively inhibits the growth of benign prostatic hyperplasia-1 cells (Park et al., 2018). Here, CASP8 is linked to benign prostatic hyperplasia.